Search

Search Results
Results 371 - 380 of 612 for Skin Cancer
  • Risperdal Tablets and Solution
    Drug - 27 Aug 2021
    Consumer Medicine Information (CMI) about Risperdal Tablets and Solution (Risperidone) intended for persons living in Australia.
  • Rukobia Tablets
    Drug - 5 Aug 2021
    Consumer Medicine Information (CMI) about Rukobia Tablets intended for persons living in Australia.
  • Valcyte Powder for Oral Solution
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Valcyte Powder for Oral Solution (valganciclovir) intended for persons living in Australia.
  • Fluanxol
    Drug - 7 Oct 2020
    Consumer Medicine Information (CMI) about Fluanxol (Flupentixol decanoate) intended for persons living in Australia.
  • Risperdal Consta
    Drug - 11 Aug 2020
    Consumer Medicine Information (CMI) about Risperdal Consta (Risperidone) intended for persons living in Australia.
  • Thioprine 50
    Drug - 12 Feb 2020
    Consumer Medicine Information (CMI) about Thioprine 50 (azathioprine film-coated tablets) intended for persons living in Australia.
  • Jadenu
    Drug - 5 Dec 2019
    Consumer Medicine Information (CMI) about Jadenu (deferasirox) intended for persons living in Australia.
  • Celaxib (New Formulation)
    Drug - 17 Apr 2025
    Consumer Medicine Information (CMI) about Celaxib (New Formulation) intended for persons living in Australia.
  • Brufen Pain
    Drug - 16 Apr 2025
    Consumer Medicine Information (CMI) about Brufen Pain intended for persons living in Australia.
  • Actonel
    Drug - 9 Apr 2025
    Consumer Medicine Information (CMI) about Actonel intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback